AKT1 and cancer: EGFR mutant NSCLC tumors evade macrophage phagocytosis via activating the AKT/NF‐κB and ERK/c‐Myc signaling pathways to increase CD47 expression,[251] which acts as a signal of “don't eat me,” preventing macrophages from phagocytosing cancer cells.[247]